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(57) ABSTRACT 
The present invention provides methods and compositions 
for preventing or inhibiting human food-borne pathogens in 
animals, and methods for increasing feed efficiency in 
animals by administering to the animal effective amounts of 
probiotic lactic acid producing bacteria. Further provided 
are feed compositions comprising probiotic lactic acid pro- 
ducing bacteria. A preferred probiotic lactic acid producing 
bacteria is Lactobacillus acidophilus strain ATCC accession 
number PTA-5249. This bacterial strain inhibits nalidixic 
acid-resistant Escherichia coli 0157:H7. 
FOREIGN PATENT DOCUMENTS 
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LACTIC ACID BACTERIA CULTURES THAT Accordingly, there is growing consensus that control of 
INHIBIT FOOD-BORNE PATHOGENS food-borne pathogens in live animals is the most effective 
strategy for further reducing human food-borne illness. 
CROSS REFERENCE TO RELATED Toward that end, vaccination has been one approach 
APPLICATION 5 employed to protect animals from carriage of microorgan- 
isms causing food-borne illness in humans. Vaccines, how- 
This application claims priority from Provisional Appli- ever, are not entirely effective in reducing the carriage of 
cation Ser. No. 601389,968 filed on Jun. 19, 2002, which is human, food-borne pathogens because many of these patho- 
hereby incorporated by reference in its entirety. gens do not actually infect the animal, but merely reside in 
l o  the animal's intestinal tract. As a result, vaccination is 
FIELD OF THE INVENTION largely ineffective in preventing the slaughter-house con- 
tamination of meat intended for human consumption. Fur- 
The invention relates to probiotic lactic acid bacteria used ther diminishing the attractiveness of a vaccine based 
to prevent or inhibit the carriage of human pathogenic approach is the growing concern that the presence of anti- 
organisms in animals. More particularly, the invention 1s biotic resistant genes in vaccines is resulting in the devel- 
relates to probiotic lactic acid bacteria selected for specific opment of resistant populations of harmful bacteria. 
characteristics useful in the prevention of carriage of human 
~ ~ ~ ~ ~ t l ~ ,  the use of competitive exclusion products 
pathogenic bacteria, including E. coli 0157:H7, in mature ( " c E ~ ) ,  such as probiotics, for inhibiting the carriage of 
ruminant animals. food-borne pathogens in live animals has shown significant 
20 promise. Competitive exclusion employs the use of live 
BACKGROUND OF THE INVENTION microbial cultures that are not harmful to the animal and are 
also not harmful to humans. These microbial cultures are 
Food-borne diseases are an important public health con- able to out food-borne pathogens in the animal's 
tern. In the United States the Occurrence intestinal tract and prevent pathogens from colonizing. The 
borne illness is estimated to be between 6 and 80 million 25 use .fa CEP based approach is thus promising, because 
illnesses with approximately 9000 deaths annually. The unlike the vaccine based approach, CEPs are able to ben- 
most prevalent agent causing food-borne illness is Campy- eficially alter the microflora in the intestinal tract of the 
lobacter jejuni. This agent alone is estimated to be respon- animal thereby reducing or eliminating the carriage of 
sible for causing 4 million of these cases with more than harmful human pathogens, 
1000 deaths annually. Although less prevalent than Campy- 30 probiotics, as discussed above, are an important class of lobacter jejuni, Salmonella (non-typhoid) is also a major CEP that have been reported to inhibit many food-borne health concern because it is responsible for 2 million cases pathogens including Escherichia coli, Campylobacter disease and 2000 deaths each year. Further, jejuni, Salmonella, and Listeria monocytogenes, Many 
more than 25,000 of these cases with more than 200 deaths classes of microorganisms are employed as probiotics 
annually have been attributed to food-borne Escherichia 35 including yeasts such as Saccharomyces and Torulopsis, 
Coli 0157:H7. And while the incidence of disease due to E. fungi such as Aspergillus, and microorganisms belonging to 
"li is much rare than many other food- the genera Bacillus and Clostridium have also been used. borne pathogens, such as Salmonella and Campylobacter, it 
is a particular concern because it is often life-threatening in Intestinal strains of lactic acid bacteria, however, are the 
children and the elderly. most widely utilized class of microorganisms as probiotics. 40 
Equally, in addition to the staggering health concerns Lactic acid bacteria are widely employed as probiotics 
associated with food-borne illness, is the severe economic because members of this group are particularly 
burden these agents cause. This economic burden is not suitable as antagonistic microorganisms in food due to their 
limited to one specific area of the economy, but stretches ability to inhibit other food-borne bacteria coupled with their 
through several sectors. For example, human health costs 45 ability to be used safely. For example, Nisbet et al. (U.S. Pat. 
associated with food-borne illness is estimated to be No. 5,340,577) reported the reduction of Salmonella con- 
approximately 22 billion dollars annually in the United centration in fowl using a probiotic mixture containing 
States alone. Equally devastating are the somewhat intan- several lactic acid bacteria. Despite these advantages and 
gible costs incurred by the livestock industry, such as S U C C ~ S S ~ U ~  use in fowl, however, lactic acid bacteria have not been employed as a means to reduce the carriage of food- treatment costs and livestock deaths, negative public per- 50 
ception, increased cull rates, reduced feed efficiency, and borne pathogens in mature ruminant 
decreased weight gain. Accordingly, a need exists for a probiotic containing lactic 
~ ~ i ~ ~ l ~  have been identified as a major source of these acid bacteria effective in treating or preventing the carriage 
food-borne illnesses when humans consume meat and other of food-borne pathogens in mature ruminant animals. The 
products contaminated with m~croorgan~sms at slaughter, 55 present invention addresses this need by providing strains of 
particular, the deadly food pathogen, E, coli 0 1 5 7 ~ ~ 7 ,  is lactic acid bacteria that may be safely and economically 
predominantly found in the intestinal tract of cattle. Food employed as ~robiotics in mature ruminant animals. 
processors and government agencies have responded to this 
problem by instituting hazard analysislcritical control point SUMMARY OF THE INVENTION 
(HACCP) models to provide food safety assurance. In fact, 60 
this program is required by the USDA in most meat and Among the several aspects of the invention, therefore, is 
poultry processing facilities. HACCP systems are designed provided a method of preventing or inhibiting the carriage of 
to systematically prevent food safety hazards from occur- human food-borne pathogens in mature ruminant animals by 
ring. While HACCP has resulted in a decreased risk of administering a probiotic lactic acid bacteria specifically 
contamination during the post-harvest period, it does not 65 selected for certain characteristics, including survivability in 
address the issue of contamination caused in the pre-harvest the gastrointestinal tract, adhesiveness to intestinal epithe- 
period. lium, antibiotic susceptibility, and technological properties. 
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Another aspect of the present invention provides a method FIG. 8 is a graphic representation of incidence of E. coli 
for increasing feed efficiency in a mature ruminant by 0157:H7 in cattle that received treatment with a CEP. This 
administering to the animal an effective amount of a com- figure is described in more depth in example 13. 
position comprising a probiotic bacterial strain. Further 
provided are feed compositions comprising the probiotic 5 ABBREVIATIONS AND DEFINITIONS 
bacterial strain. 
Other features of the present invention will be in part TO facilitate understanding of the invention, a number of 
apparent to those skilled in the art and in part pointed out in terms and abbreviations as used herein are defined below: 
the detailed description provided below. "CGF" stands for corn gluten feed. 
10 "d" stand for days. 
BRIEF DESCRIPTION OF THE DRAWINGS "DRC" stands for dry rolled corn diet. 
"Enteropathogenic" shall include a microorganism 
These and other features, aspects, and advantages of the capable of causing disease in the intestinal tract. 
present invention will become better understood with regard "Food-borne Pathogenic Bacteria" shall include a micro- 
to the following description, appended claims and accom- 15 o ~ a n i s m  that is pathogenic to humans when present in food 
panying figures where: that is consumed by a human. 
FIG. 1 depicts the nomenclature of isolates based on diets, "HMC" stands for high moisture corn diet. 
sample collection from cattle at 3, 6, 9 and 12 weeks, and "h" stands for hour. 
number of isolates from each sample, The letters A through The term "inhibition" when used herein in phrases such as 
represent each animal in a diet group from which fecal 20 "carriage inhibition" or "inhibition of carriage" means a 
samples were collected, p1 through p4 represent the tirne decrease in growth, in terms number target bacteria, as 
periods at which samples were collected; P1 represents the to the growth Or concentration that occur in 
first 3-week interval, P2 represents the second 3-week the absence of the application of the method of the inven- 
interval, P3 represents the third 3-week interval, and P4 tion. 
represents the fourth 3-week interval (for a total of 12 25 "lb" Stands for pound. 
weeks). All-T415 represent isolated colonies, with each "Mature Ruminant" shall include a ruminant having a 
colony collected from a given animal (A through at a stomach wherein all four compartments are functioning. 
given period of time (PI through P4). For example, A215 "Probiotic" shall include a mono- or mixed culture of live 
represents isolate number 15 obtained during the second microorganisms which, to a man Or (e.g., as 
3-week interval from animal A. 30 dried cells or as a fermented product), affects beneficially the 
host by improving the properties of the indigenous microf- FIG. 2 is a graphic representation of inhibition of E. coli lora. 0157:H7 using the agar spot test, as further described in 
Example 2, by strains isolated from cattle fed 3 different "Ruminant" shall include mature and immature animals 
diets: corn gluten feed diet, dry rolled corn diet, high with multi-compartment stomachs, including but not limited 
35 to, cattle, sheep, deer, goats, musk, ox, buffalo, giraffe and 
moisture corn diet. 
camels. For example, cattle and sheep have a stomach with FIG. 3 is a graphic representation of inhibition of E. coli four compartments comprising the rumen, reticulum, oms- 0157:H7 by several different lactic acid bacteria strains in 
sum, and abomasum, 
manure. These strains and the interaction test are described 
in more depth in example 7 and in the examples accompa- 
40 
nying tables. The control sample contained only the E. coli DESCRIPTION OF THE PREFERRED 
0157:H7 strain. Bars with different letters are sianificantlv EMBODIMENTS 
- 
(Pe0.05) different. An efficient, safe, and economical method to prevent or 
FIG. 4 is a graphic representation of inhibition of E. coli treat the carriage of food-borne, pathogenic bacteria in 
0 1  57:H7 by lactic acid bacteria in rumen fluid. These strains 45 mature ruminant animals has been discovered, This method, 
and the interaction test are described in more depth in .dike previous approaches, advantageously comprises 
and in the The administering to the mature ruminant an effective amount of 
control sample contained only the E. coli 0157:H7 strain. a probiotic containing one to several strains of lactic acid 
Bars with different letters are significantly (Pe0.05) differ- bacteria ("LAB"), LAB, as previously stated, are particu- 
ent. 50 larly beneficial for use as a probiotic due to their ability to 
FIG. 5 is a graphic representation of inhibition of E. coli inhibit other food-borne bacteria coupled with their ability to 
0157:H7 by competitive exclusion product (CEP) in be used safely in food to be consumed by humans. Several 
manure. UNL represents a mixture of isolates M35 (ATCC strains of LAB that are suitable for use as a probiotic to 
accession no. PTA-5249) and LA45. NPC represents a prevent or treat the carriage of food-borne, pathogenic 
mixture of commercial strains LA51 and LA45. The control 55 bacteria in mature ruminant have been discovered, 
sample contained only the E. coli 0157:H7 strain. The probiotics employed in the present invention, as 
FIG. 6 is a graphic representation of inhibition of E. coli stated above, generally prevent or treat the carriage of 
0157:H7 by competitive exclusion product (CEP) in rumen food-borne, pathogenic bacteria in ruminant animals, It is 
fluid. UNL represents a mixture of isolates M35 (ATCC believed, without being bound by any particular theory, that 
accession no. PTA-5249) and LA45. NPC represents a 60 the probiotics employed in the invention act by competitive 
mixture of commercial strains LA51 and LA45. The control exclusion ("CW). Competitive exclusion is the use of live 
sample contained only the E. coli 0157:H7 strain. microbial cultures that exhibit antagonistic effects against 
FIG. 7 is a graphic representation of incidence of E. coli specific groups of organisms, such as food-borne pathogens, 
0 1  57:H7 in 180 cattle (60ltreatment) after treatment with a resulting in the overall decrease in numbers of the pathogen 
competitive exclusion product (CEP). The CEPs, 747 and 65 in the intestinal tract. Although not well studied, the mecha- 
750, as well as the control are described in more depth in nisms by which competitive exclusion products exclude 
example 13. pathogens from the intestinal tract that have been observed 
5 6 
include: (1) production of antibacterial agents (bacteriocins) (c) Antibiotic Susceptibility 
and primary metabolites (organic acids and hydrogen per- It is believed that antimicrobials used in food-producing 
oxide) that may inhibit pathogenic microflora; (2) competi- animals can promote the emergence of resistance in probi- 
tion for nutrients; and (3) competition for adhesion sites on otics that can lead to transfer of resistance to other patho- 
the gut epithelial surface that may prevent colonization by 5 genic bacteria by exchange of genetic material, or it can 
pathogenic microorganisms. increase the potential threat posed by these organisms as 
Typically the probiotic may be administered to a number opportunistic pathogens. In one embodiment, therefore, the 
of different animals. In general, however, probiotic LAB are LAB is not resistant to antibiotics. In another embodiment, 
host specific. Thus, for example, Lactobacillus isolated from the LAB is typically not resistant to more than 4 of the 
a specific site of a specific animal source typically colonizes l o  following antibiotics: erythromycin, tetracycline, ampicillin, 
epithelium of the same kind. Generally, therefore, LAB are grepafloxicin, levofloxacin, trimthoprimisulfamethoaxo- 
isolated from an animal species and administered as a zole, vancomycin, cephalothin and polymixin B. In yet 
probiotic to an animal from the same species. In one another embodiment, the LAB is not resistant to more than 
embodiment, LAB are isolated from mature ruminants for 2 of the above-identified antibiotics. In still another embodi- 
use as probiotics in mature ruminants. It is, however, also 1s ment, the LAB is not resistant to any of the above-identified 
envisioned that LAB may be isolated from a variety of antibiotics; and 
livestock animals, including but not limited to, fowl, equine, (d) Technological Properties 
ruminants and porcine and administered as a probiotic to the The probiotic LAB generally undergoes several process- 
particular animal species. The methods described herein ing steps before use as a feed supplement. Such processing 
enable one skilled in the art to isolate the corresponding 20 steps may involve, separation by centrifugation or filtration, 
probiotic LAB in a target animal. Equally, any known fermentation in cultured products, and freeze-drying or 
method for bacterial isolation, modified for mature ruminant lyophilization. Therefore, the LAB should be able to with- 
animals, may be employed, such as, for instance, methods stand stresses associated with these procedures such as 
described in Buck, L. M. and S. E. Gilliland., Comparisons freezing, high pressure and temperatures (60-80" C. for 5-10 
of freshly isolated strains of Lactobacillus acidophilus of 25 minutes during pelleting) and should have a high growth rate 
human intestinal origin for ability to assimilate cholesterol and achievable cell mass. In addition, the LAB should be 
during growth. J. Dairy Sci. 77: 2925, 1994. able to retain its viability under storage conditions. 
The probiotics employed in the present invention typi- LAB bacteria possessing the desired characteristics 
cally comprise from one to several strains of LAB. In one described above may be employed as a probiotic in the 
embodiment, the probiotics comprise from one to ten dif- 30 present invention. Typically, however, the LAB is selected 
ferent strains of LAB. In yet another embodiment, the from among the genera Lactobacillus, Lactococcus, Leu- 
probiotic comprises from two to five different strains of conostoc, Pediococcus, Enterococcus and Streptococcus. In 
LAB. In still another embodiment, the probiotic comprises one embodiment the LAB employed as a probiotic is from 
more than ten different strains of LAB. the genera Lactobacillus. In yet another embodiment, the 
In general, LAB constitute a group of Gram-positive 35 strain of Lactobacillus is selected from L. acidophilus, L. 
bacteria that share similar morphologic, metabolic and bulgaricus, L. helveticus, L. casei, L. lactis, L. plantarum, L. 
physiologic characteristics. These bacteria are non-spore rhamnosus, L. reuteri, L. fermentum, L. brevis, L. delbreukii, 
forming rods and cocci that ferment carbohydrates forming L. cellobiosus, and L. salivarius. 
lactic acids as the major end-product, hence giving way to In yet another embodiment, the probiotic comprises a 
the name LAB. Depending on the metabolic pathways used 40 LAB strain isolated based upon the criteria set forth above 
to ferment carbohydrates and the resulting end products, and depicted in the examples below. This strain has been 
LAB are divided into two major groups, homofermentative identified as L. acidophilus M35 (also referred to herein as 
or heterofermentative. They are generally catalase-negative, M35 only)(ATCC accession no. PTA-5249). 
anaerobic in nature, non-motile and do not reduce nitrate. The probiotic can be administered to the animal by a 
LAB are widespread in nature with distribution common in 45 method likely to introduce the LAB into the digestive tract. 
milk and dairy products, other fermented foods, intact and In one embodiment, lyophilized LAB is thawed and mixed 
rotting vegetable material, silage and intestinal tracts and with the animal's feed or drinking water. Lyophilization 
mucous membranes of man and animals. (freeze-drying) can be performed by freezing a bacterial 
Typically, for a LAB to be a useful probiotic to prevent or culture and concentrating it under vacuum to sublime the 
treat the carriage of food-borne, pathogenic bacteria in 50 water from the frozen preparations. Briefly, cells are har- 
mature ruminant animals, the bacteria are typically isolated vested by centrifugation, resuspended in lyophilization 
from mature ruminant animals and are selected so that they media and frozen at -70' C. in lyophilization vials. Vials are 
possess certain characteristics. In the present invention, the then placed on the lyophilizer and lyophilized for, e.g., 3 
LAB employed as a probiotic typically have the following hours at e.g., Itoreq 20 millitorrs and -100" C. The vials are 
features: 55 next sealed and stored at refrigerated or freezer temperatures 
(a) Survival in the Gastrointestinal Tract until rehydration. Modifications to this protocol, depending 
The probiotic LAB of the present invention should be able on the cells to be lyophilized, can be easily made by one of 
to survive and metabolize in the intestine of the mature ordinary skill in the art. 
ruminant. This means that the strain is typically resistant to It should be noted that several factors play a role in 
gastric acid juices, low pH, enzymes, organic acids and bile 60 viability and storage time of lyophilized bacteria. First, at 
and pancreatic secretions; the time of harvesting, it is preferable that the cultures are 
(b) Adhesion to Intestinal Epithelium healthy and actively growing in either the logarithmic or 
The probiotic LAB of the present invention should have early stationary phase, and have a density of about 108/ml. 
good adhesion properties to the intestinal cells of the mature It is also important that the medium for cell preservation 
ruminant thereby enhancing colonization of the LAB. Adhe- 65 contains a cryoprotective reagent, such as, e.g., skim milk, 
sion is also desired to prevent the LAB from being washed sucrose, serum, inositol, or dextran. However, it should also 
away by contents of the stomach, intestine and by peristalsis; be noted that the selection of media and cryoprotective 
US 7,323,166 B2 
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agents is an empirical process that depends on bacterial cells EXAMPLES 
to be lyophilized. A skilled artisan can easily determine 
optimal lyophilization conditions for particular bacteria. In It is understood that the foregoing examples are given by 
addition, methods for preserving cells, including the lyo- way of illustration and that modifications and variations may 
philization methods are numerous and well known in the art. 5 be made therein without departing from the spirit and scope 
See, for instance, Maintenance of Microorganisms, Kirsop, of the invention. 
B. E., and Snell, J. J. S., Eds., (1984), Academic Press, New 
York). Alternatively, lyophilization of bacteria is commer- Example 1 
cially available. 
In another embodiment, the LAB is mixed with a carrier 
lo Isolation of Strains of LAB From Healthy Cattle 
and applied to liquid or solid feed or to drinking water. The 
carrier material should be non-toxic to both the LAB and the Cattle that were fecal culture negative for E. coli 0 1  57:H7 
animal. The carrier will generally contain an ingredient that were for LAB 
promotes viability ofthe LAB during storage, When admin- l5 that were to be screened for inhibitory activity towards E. 
istered in feed or drinking water the dosage can be spread coli 0157:H7. Manure sample from the Animal Science 
over a period of days or even weeks. In yet another embodi- Department of University of Nebraska-Lincoln (UNL) were 
obtained at three-week intervals over a period of twelve 
ment, the LAB is formulated as an inoculant paste to be 
weeks (4 sampling periods) from cattle that were fed three directly injected into an animal's mouth. The formulation different finishing diets, (1) High Moisture Corn (HMC), (2) 
can include additional ingredients to improve palatability, 20 Dry Rolled Corn (DRC), and (3) Corn Gluten Feed (CGF) 
improve shelf-life, impart nutritional benefits, and the like. (Table 1). Samples were collected separately from 5-7 cows 
In still a further embodiment, if a reproducible and measured from each diet group and numbered as illustrated in FIG, 1, 
dose is desired, the LAB can be administered by rumen One gram of each fecal sample was added to ml of 
cannula. 25 sterile de Man-Rogosa-Sharpe (MRS) broth (Difco Becton 
The effective amount of probiotic administered to the Dickinson Microbiology Systems, Sparks, Md,) and mixed 
animal is a quantity to achieve the desired carriage inhibition thoroughly by shaking. The fecal material was then plated 
of food-borne, pathogenic bacteria. This effective amount on Lactobacillus Selection (LBS) agar (BBL Becton Dick- 
can vary depending on many factors, such as, the size of the inson Microbiology Systems, Cockeysville, Md.) and MRS 
animal, the species of the animal, the age of the animal, the 30 agar plates using the streak-plate method. The plates were 
particular active compound used, the dosage form employed incubated at 37O C. for 48 hours in plastic bags flushed with 
or the particular sensitivity of the particular animal. The CO, for 30 seconds. Approximately 10 to 15 well-isolated 
optimum range of an effective amount, based on variables colonies were picked from each plate and transferred to 
such as those mentioned above, can be found using conven- individual tubes containing 10 ml of MRS broth, which were 
tionally known techniques, for example, such as, dose 35 further incubated at 37' C. for 18-72 hours to obtain 
titration determinations or any other method generally maximum growth of the cultures. The isolated cultures were 
known in the veterinary sciences. For example, by monitor- restreaked onto LBS and MRS agar plates and incubated at 
ing the numbers of target pathogen in the feces before, 37O C. for 48 hours. This process was repeateduntil only one 
during and after administration of probiotic, the skilled colony morphology appeared. Following isolation, pure 
artisan can readily ascertain the dosage level. 40 colonies were Gram-stained according to the Bergey's 
In one embodiment, the probiotic is administered as a Manual of Determinative Bacteriology (Sneath P. H. A,, N. 
preventative, to prevent animals not presently carrying the S. Mair, M. E. Sharpe, and J. G. Halt (ed.), Bergey's Manual 
pathogen from acquiring the strain by exposure to other of Systematic Bacteriology, Williams and Wilkins, MD.) for 
animals or environments where the pathogen is present. In preliminary identification. The isolated cultures were main- 
yet another embodiment, the probiotic is administered to 45 tained as frozen (-70" C.) stocks in MRS broth supple- 
treat animals carrying a pathogen. For example, animals mented with 10% (v/v) sterile glycerol. Isolates were sub- 
known to be shedding a pathogen in feces, or those raised cultured in MRS broth at 37' C. for 24-48 hours before they 
where a pathogen is known to exist are suitable candidates were used for further studies. 
for treatment with probiotic. The methods for administering 
probiotic are essentially the same, whether for prevention or 50 TABLE 1 
treatment. 
The probiotic LAB of the present invention may be 
administered to a mature ruminant to prevent or treat the 
Composition of diets fed to cattle 
utilized for isolation of bacteria 
carriage of a number of target food-borne, pathogenic bac- Ingred~ent" HMC DRC CGF 
teria for which the probiotic is effective against. In general, 55 A I ~ ~ I ~ ~  7 50% 75 50% 7 50% . .. . -.  - . . .. .
the term "food-borne, pathogenic bacteria" means that the Molasses 3.0% 3.0% 
bacteria is pathogenic to humans. Depending on the particu- ~upplemental" 5.0% 5.0% 5.0% 
lar strain of LAB utilized, however, the probiotic may also HMC 84.5% - - 
DRC - 84.5% 47.5% be effective against bacteria that are pathogenic to the host CGF - - 40.0% 
animal, such as mature ruminant animals. In one embodi- 60 
ment, the target food-borne, pathogenic bacteria is a strain of HMC - High Moisture Corn; DRC - Dry Rolled Corn; CGF - Corn Gluten 
human enteropathogenic bacteria. In yet another embodi- ?$matter basis 
ment, the human enteropathogenic bacteria is selected from 
"pmtein mineral and "itamins 
Campylobacter jejuni, Salmonella, Escherichia coli, List- 
eria monocytogenes, and Vibrio. In still another embodi- 65 Six hundred eighty-six isolates were obtained; 15% were 
ment, the target bacteria is Escherichia coli. In yet another Gram-negative and 85% were Gram-positive bacteria with 
embodiment, the target bacteria is E. coli 0157:H7. 72% Gram-positive rods and 27% Gram-positive cocci, as 
US 7,323,166 B2 
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determined by the Gram-staining procedures followed by oxgall or without oxgall (control). The inoculated tubes were 
microscopic examination. Isolates were obtained from all incubated at 37' C. in a water bath. Growth of the organisms 
animals on all diets. was monitored at 0, 2, 4, 6, and 24 hours by measuring 
absorbance at 660 nm. The test for each strain was repeated 
Example 2 5 three times. 
Bile tolerance studies indicated that all isolates except 
Screening Isolated Colonies for Inhibition Towards A22 showed increased growth rate under all bile conditions 
E. coli 0157:H7 (0. 0.5, 0.15, and 0.30%). However, when compared with 
other treatments, the growth was slightly decreased for 
Isolated strains were initially screened for inhibition 10 treatment containing 0.3% oxgall but showed a gradual 
towards E. coli 0157:H7 using the agar spot test. An increase over a 24 hour period with the following excep- 
overnight culture of each cattle isolate to be tested was tions: (i) strains C l l l  and M38 showed reduced growth for 
prepared by inoculating stock culture in 10 ml of MRS 0.3% oxgall at 24 hours, and (ii) strains F111, T28, 4311, 
broth. Cultures of individual strains were then spot-inocu- and J49 did not grow well at 0.3% oxgall at all incubation 
lated onto the surface of MRS agar plates and incubated for 15 periods, 
24-48 hours at 37' C. in plastic bags flushed with CO, for 30 
seconds. A four-strain mixture of E. coli 0157:H7 was used Example 4 
to screen the isolates for inhibitory activity towards E. coli 
0157:H7. The E. coli strains used in the study were origi- Storage Stability 
nally obtained from the laboratory of Charles Kaspar (Food 20 
~eskarch  Institute, University of Wisconsin,  adi is on,   is.) Nineteen of the 75 isolates selected for further studies 
and included strains 920, 922, 944, and 966 (all cattle 
were tested for storage stability in a commercial freezer (0" isolates). Overnight cultures of E. coli strains were prepared C.). Following isolation, an overnight culture of each isolate (5x108 CFU1ml) l o  m1 t ~ ~ t i c  was prepared in MRS broth and supplemented with 10% 
(TSB) (Difco Becton Dickinson Microbiology Systems, 25 (vlv) sterile glycerol. About 1 ml of each culture was then 
'parks, Md.) with (-700 stocks of each E. "li dispensed into sterile 1.5 ml cryogenic vials and frozen at 
strain and incubating at 37' C. for 18-24 hours. 
-70" C. These frozen stocks were transferred the next day to 
numbers were determined pour-plating each 
a freezer set at 00 C, Viability of the isolates was tested at 0, 
On t ry~tic  agar (TSA) (DifcO), using and after 3 months of storage in the commercial freezer by 
appropriate dilutions, and incubating at 37' C. for 18 hours. 30 plating on MRS agar and incubating at 370 C, for 
The cocktail of E. coli 0157:H7 was prepared by placing 1 hours, 
ml of the overnight culture of each strain into a sterile 
test-tube and thoroughly mixing. About 1 ml of the cocktail At the end of all the screening procedures (24 months), 
mixture was inoculated into 10 ml of tempered soft TSA to the isolates finally selected as competitive exclusion prod- 
obtain a final concentration of approximately 5x107 CFUI 35 ucts (CEP) were tested for viability by plating concentrated 
ml. This mixture was then poured onto the surface of cultures on MRS agar (at appropriate dilutions) and incu- 
spot-inoculated agar plates that contained well-grown test bating at 37O C. for 18-24 hours. Colonies were counted after 
isolates. After 24 hours of incubation at 37' C., inhibitory incubation to determine the actual population. 
activity of the test isolate was measured as the size of All isolates maintained their viability over a period of 3 
inhibition zones around the colony, inhibition was consid- 40 months of storage at 0' C. with the exception of isolates A43 
ered significant when the width of the clear zone around the andA46 that did not survive storage in a commercial freezer. 
colonies of the isolated strains was 0.5 mm or larger. The test Isolates M35 (ATCC PTA-5249) and L41 that 
for each isolate against the pathogen cocktail was replicated were as CEP showed good after 24 months 
three times. of storage at -70' C. A population of about lxlo9 CFUIml 
All 686 isolates were tested for inhibition towards E, coli 45 was obtained for both the isolates after culturing on MRS 
0157:H7 using agar spot test. Three hundred fifty-five agar. 
isolates (52%) met or exceeded the inhibition criteria (inhi- 
bition zone 20.5 mm) and 275 isolates (40%) produced Example 5 
inhibition zones near or greater than 1 mm. The inhibition 
zones ranged from 0.5 mm to as large as 12 mm. Results are 50 Preliminary Identification of Isolates Using 
shown in FIG. 2. In addition, for specific values of a number Analytical Profile Index (API) 
of isolates, see Table 3 (inhibition column). 
Based on their inhibitory activity towards E. coli 0157: 
Example 3 H7, and tolerance to acid and bile, 75 isolates were chosen 
55 for identification by fermentation patterns using standard 
Test for Bile Tolerance API (bioMkrieux, Inc., Hazelwood, Mo.) tests. API SOCHL, 
API 20Strep, and API 20E were used to identify Gram- 
The isolates that were most inhibitory towards E, coli positive rods, Gram-positive cocci and Gram-negative rods, 
0 1  57:H7 in the agar spot test were selected for bile tolerance respectively. 
tests. The method used for testing bile tolerance was similar 60 Based on the API, some of the isolates were eliminated 
to the one described by Gilliland et al. (Gilliland, S. E., because either their identification was not clear (unaccept- 
Stanley, T. E., and Bush, L. J. 1984. Importance of bile able or doubtful profile) or they were not LAB. The most 
tolerance of Lactobacillus acidophilus used as a dietary commonly identified strains of LAB according to API were: 
adjunct. J. Dairy Sci. 67: 3045-3051). An overnight culture Lactobacillus acidophilus, L. fermentum, L. delbreukii, L. 
of the selected isolates was prepared in 10 ml MRS broth 65 salivarius, L. brevis, L. cellobiosus, Leuconostoc spp., and 
and 0.1 ml of the culture suspension was inoculated into Pediococcus acidilactici (Table 2). Of the 75 isolates iden- 
tubes containing 10 ml MRS broth with 0.5, 0.15, 0.3% tified and screened for bile tolerance, 19 were selected for 
US 7,323,166 B2 
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further interaction studies in the manure and rumen fluid. A Example 6 
list of the selected isolates along with their API profiles is 
given in Table 3. Test for Antibiotic Resistance 
TABLE 2 
Identification of cattle 
isolates bv Analflical Profile Index 
Cattle 
Isolate API Used Identification" % Homology 
M17 50 CHL L. fermentum 91.5 
KllO 50 CHL L. brevis 99.7 
H27 50 CHL L. delvreukii ss. delb. 88.5 
I212 50 CHL L. salivanus 99.9 
The isolates selected after API results were further 
screened for resistance to a panel of 6 antibiotics represent- 
ing two of the three categories of antimicrobial drugs 
suggested by FDA, that are commonly used in animals and 
lo  humans. The following are examples of types of drugs that 
would be included in the three categories: Category I: 
quinolones, vancomycin, dalfopristidquinupristin, third 
generation cephalosporins; Category 11: ampicillin, first and 
second generation cephalosporins, erythromycin, trimetho- 
~ 2 1  50 CHL L. brevis 99.5 15 prindsulfamethoxazole; and Category 111: inophores (mon- 
T28 50 CHL L. acidophilus 82.5 ensin) and polymixins (Polymixin B and colistin). The 
C314 50 CHL L. acidophilus 88.3 
I33 50 CHL L. brevis 99.5 antibiotics used in the present study included erythromycin 
M35 50 CHL L. acidophilus 98.5 (EM), ampicillin (AM), tetracycline (TC), trimethoprind 
037 50 CHL L. cellobiosus 97.2 sulfamethoxazole (TS), grepafloxacin (GP) (quinolone), and 
B41 50 CHL L. fermentum 98.9 
L411 50 CHL L. acidophilus 84,2 20 levofloxacin (LE) (fluoroquinolone). A commercial antimi- 
T21" 20 strep Leuconostoc spp. 98.3 crobial susceptibility test kit-Etest (AB Biodisk, North 
P32 50 CHL L. brevis 99.4 America Inc., Piscatway, N.J.) was used to determine the 
A43 50 CHL L. acidophilus 87.5 
A46 50 CHL L. acidophilus 99.2 minimum inhibitory concentrations (MIC) of the antibiotics 
C315 50 CHL Pediococi acidilactici 99.8 for the isolates selected. Etest strips containing a predefined 
M38 50 CHL L. acidophilus 95.8 25 exponential gradient of a particular antibiotic were applied 
S310 50 CHL L. acidophilus 60.3 to agar plates containing Mueller Hinton Agar (Difco) 
R44 50 CHL L. acidophilus 95.8 pre-inoculated with an overnight culture of the given bac- 
"Identification to genus level only teria (inoculum of 0.5 McFarland turbidity in 0.85% NaCl). 
30 The agar plates with the strips were immediately incubated 
at 37" C. for 16-20 hours, when bacterial growth became 
TABLE 3 distinctly visible. After incubation, MIC values (pglml) were 
Cattle isolates chosen for further analysis read where the inhibition ellipse (centered along the strip) 
based on inhibition" towards E. coli 0157:H7, Gram intersected the scale at the edge of the strip. The suscepti- 
reaction. bile tolerance" and Analvtical Profile Index 35 bility categorization of organisms towards a specific antibi- 
Inhibition 
otic was provided in the Etest antibiotic supplements for 
Isolate (mm) Gram R X ~ .  API each agent and was used to examine the susceptibility of 
lactic acid bacteria (LAB) isolates. Based on the cateaori- 
\ ,  - 
C315 11.47 cocci+ PediOcOccus acidilactici zation, MIC for a particular organism was reported as 
A46 8.87 Rods+ L. acidophilus 
C314 8.13 Rods+ L. acidophilus 40 susceptible (S), intermediate (I), or resistant (R). The sus- 
M35 6.00 ~ o d s +  L. acidoahilus ceptibility categories of each antibiotic are given in Table 4. 
M3 8 4.33 Rods+ L. acidophilus When growth occurred along the entire st&, i.e. no inhibi- 
- - 
S310 4.20 Rods+ L. acidophilus tion ellipse was seen, the MIC was reported as greater than 
B41 3.45 Rods+ L. fermentum 
R44 3.15 ~ o d s +  L. acidophilus (>H) the highest value on the reading scale. When the 
1212 2.89 ~ o d s +  L. salivanus ,, inhibition ellipse was below the strip, i.e. the zone edge did 
7 d  
037 2.78 ~ o d s +  L. cellobiosus not intersect the strip, MIC was reported as less than (<L) the 
L411 2.03 Rods+ L. acidophilus lowest value on the reading scale. 
H27 1.71 Rods+ L. delbreukii. delbreukii 
A43 1.65 Rods+ L. acidophilus Of the 19 strains tested, 21% (4 of 19) (M35 (ATCC 
P3 1 1.45 Rods+ L. acidophilus accession no. PTA-5249). A43. C312. and 1212) showed 
, , 
C312 1.39 ~ o d s +  L. acidophilus 50 susceptibility to all the antibiotics. Most isolates were resis- 
T2 1 1.07 Cocci+ Leuconstoc spp. 
T28 1.03 Rods+ L. acidophilus tant to trimethoprindsulfamethaxozole and grepafloxacin 
I33 1.01 ~ o d s +  L. brevis (63% and 58% respectively). Thirteen of 19 isolates (68%) 
P32 .97 ~ o d s +  L. brevis showed multiple resistance (22)  patterns most commonly to 
trimethoprindsulfamethaxozole, grepafloxacin, and tetracy- 
"Agar Spot Test: Inhibition measured as the size of clear zone (in mm) 
around the colony 55 cline. Only one isolate (B41) was resistant to levofloxacin 
"Bile tolerance not shown. All isolates were resistant to all bile conditions. and two isolates (T28 and C314) were resistant to ampicillin. 
Results are shown in Tables 4 and 5. 
TABLE 4 
Minimum inhibitory concentrations 
(dm I) of antibiotics" for cattle isolates 
Isolates EM TS GP AM LE TC 
I33 3.00 (I) 0.44 (S) 1.2 (I) 0.03 (S) 2.3 (I) 56.0 (R) 
037 0.14 (S) >H (R) 9.0 (R) 0.75 (S) 3.0 (I) 2.5 (S) 
13 
TABLE 4-continued 
Minimum inhibitory concentrations 
(dm I) of antibiotics" for cattle isolates 
Isolates EM TS GP AM LE TC 
>H (R) 
0.16 (S) 
>H (R) 
0.11 (S) 
<L ( 9  
<L ( 9  
0.11 (S) 
<L ( 9  
0.11 (S) 
>H (R) 
0.24 (S) 
8.00 (R) 
<L ( 9  
0.22 (S) 
0.06 (S) 
0.22 (S) 
0.13 (S) 
>H (R) 
>H (R) 
>H (R) 
>H (R) 
1.50 (S) 
<L ( 9  
>H (R) 
<L ( 9  
>H (R) 
6.19 (R) 
>H (R) 
0.2 (S) 
<L ( 9  
>H (R) 
0.75 (S) 
>H (R) 
>H (R) 
12.0 (R) 
6.0 (R) 
12.0 (R) 
7.5 (R) 
0.10 (S) 
<L 6') 
7.0 (R) 
<L 6') 
8.0 (R) 
6.25 (R) 
1.0 (S) 
2.25 (I) 
<L 6') 
7.0 (R) 
0.56 (S) 
6.0 (R) 
4.5 (R) 
0.87 (S) 
0.87 (S) 
1.12 (S) 
0.87 (S) 
48.0 (R) 
0.50 (S) 
0.87 (S) 
<L ( 9  
0.09 (S) 
>H (R) 
0.56 (S) 
0.11 (S) 
<L ( 9  
1.13 (S) 
0.02 (S) 
0.75 (S) 
0.75 (S) 
2.5 (I) 
2.0 (S) 
2.0 (S) 
1.5 (S) 
0.1 (S) 
<L 6') 
2.0 (S) 
<L 6') 
3.0 (I) 
2.3 (I) 
17.5 (R) 
3.0 (I) 
<L 6') 
2.25 (I) 
0.62 (S) 
2.0 (S) 
1.5 (S) 
>H (R) 
1.75 (S) 
32.7 (S) 
1.2 (S) 
1.5 (S) 
<L ( 9  
2.0 (S) 
<L ( 9  
2.0 (S) 
30 (R) 
>H (R) 
>H (R) 
<L ( 9  
1.9 (S) 
0.2 (S) 
1.5 (S) 
1.3 (S) 
"EM = Erythromycin; TS = Trimethoprim/Sulfmthoxazole; GP = Grepafloxacin; AM = 
Ampicillin; LE = Levofloxacin; TC = Tetracycline; H = Highest MIC value on the scale; 
256 g/ml for EM, AM, TC and 32 glml for TS, GP, LE; L = Lowest MIC value on the 
scale 
(1) Selection of Nalidixic Acid-resistant Strains of E. coli 
0157:H7: 
The E. coli 0157:H7 strains that were used in the initial 
Susce~tibilitv Categorization of Antibiotics (MIC in g/m I): 30 inhibition study using agar spot test were selected for 
Susceptible (S) Intermediate (I) Resistant (R) nalidixic acid-resistance. MacConkey Sorbitol agar (MSA) (Difco) was prepared supplemented with the following 
EM 4 8 16 concentrations of nalidixic acid (ICN Biomedicals Inc., 
TS 0.5 1-4 8 
GP 2 4 8 Aurora, Ohio: 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.4, 12.0, 8.0, 25, 
AM 8 16 32 35 and 50 pglrnl). About 0.1 ml of a well-grown overnight 
LE 1 2 4 culture of each E. coli 0157:H7 strain was placed into 
TC 2 4 separate petri dishes and overlaid with MSA containing 0.1 - 
pglml of nalidixic acid. The plates were incubated at 37' C. 
for 18 hours. About 3-5 well-isolated colonies were then 
TABLE 5 40 transferred to TBS, supplemented with 0.1 pglml nalidixic 
acid, and incubated further at 37' C. for 18 hours. The cells 
Test of antibiotic resistance in grown in TSB with 0.1 pglml nalidixic acid were then 
cattle isolates towards various antibiotics overlaid with MSA containing 0.2 pglml of nalidixic acid. 
Antibiotic" % Susceptible % Intermediate % Resistant The entire process was repeated with increasing concentra- 
45 tions of nalidixic acid in the media each time until cells were 
EM 74.0 5.0 21.0 selected that were resistant to 50 pglml of nalidixic acid. 
AM 90.0 0.0 10.0 
TC 69.0 0.0 31.0 (2) Antagonistic Action of Cattle Isolates Against E. coli 
TS 37.0 5.0 63.0 0157:H7 in Manure: 
GP 32.0 10.0 58.0 A fresh overnight culture of each selected cattle isolate 
LE 58.0 37.0 5.0 50 was prepared in 10 ml of MRS broth. Freshly prepared 
"EM . ~ r y t h ~ ~ ~ ~ ~ i ~ ;  AM . bpic i l l n ;  TC . ~ ~ ~ ~ ~ ~ ~ l i ~ ~ ;  TS . ~ ~ i ~ ~ t h ~ .  culture of each of the four strains of nalidixic acid-resistant 
prim/Sulphamethoxazole; GP - Grepafloxacin; LE - Levofloxacin E. coli 0157:H7 was inoculated into 10 ml of TSB and 
incubated for 18 hours at 37' C. A cocktail was prepared 
from all four strains by mixing them together. Manure 
Example 7 55 sample of cattle was obtained from the Animal Science 
Department, UNL, on the day of the experiment and about 
Test for Inhibition Against E. coli 0157:H7 in 20 g was reserved for uninoculated control. The uninocu- 
Rumen Fluid and Manure lated control was used to make sure that no bacteria (that 
mav be resistant to nalidixic acid) other than the E. coli 
Nineteen isolates, selected from the previous screening 60 0157:H7 strains added to the samples were being recovered 
methods, were further tested for their antagonistic action on MSA supplemented with nalidixic acid. About 400 grams 
of manure sample was inoculated with 0.4 ml of E. coli 
against strains of E. coli 0 1  57:H7 that were resistant to 01 57:H7 cocktail to obtain a population of x105 CFUlml 
nalidixic acid. E. coli 0157:H7 strains were selected for which was divided into 20 sterile whirl pack bags (20 
nalidixic acid-resistance to facilitate their recovery on the 65 each), ~~~~i~~ one manure sample for inoculated control, 
media during the interaction studies and to prevent back- each of the other samples was inoculated with 2 ml(1 X 107 
ground microflora from manure and rumen. CFUlml) of the fresh MRS broth cultures of LAB (1 
US 7,323,166 B2 
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isolatelmanure sample). Each of the samples thus obtained log,, CFUlml to 1.0 log,, CFUlml). No change in pH was 
were incubated at 37' C. and plated in duplicates on MSA observed for any of the treatments, with pH values ranging 
supplemented with nalidixic acid (50 pglml) at 0, 24 and 48 between 6.0-6.3. 
hours to monitor E. coli 0157:H7 growth. The pH of each In order to be able to select final strains for the CEP, 
manure sample was recorded at 0, 24, and 48 hours, The 5 isolates were also compared against each other for inhibition 
entire experiment was repeated three times. towards E. coli 0157:H7. None of the strains were different 
from each other in their inhibition against E. coli in manure. 
(3) Antagonistic Action of Cattle Isolates Against E. coli However, in the rumen fluid it was found that at 24 hours, 
0 1  57:H7 in Rumen Fluid: strains H27, M35 (ATCC accession no. PTA-5249) andA43 
T~ rumen conditions, as per the method used by 10 were most inhibitory towards E. coli 0157:H7 compared to 
de Vaux et al,, Displacement of Escherichia coli 0157:H7 the other strains whereas at 48 hours, strains C314, M38, 
from rumen medium by prebiotic sugars, Appl, Environ, A46, L411 and R44 along with the aforementioned strains 
Microbial, (in press), fresh bovine fluid obtained also showed significant reduction in E. coli counts when 
from theAnimal Science Dept,, UNL, was mixed with glL compared to the rest of the strains(PS0.05). Uninoculated 15 manure samples were also plated at each incubation period 
corn starch, 2 glL maltose and equal parts of phosphate to make sure no background microflora, that may be mis- buffer (272 m1 of 0'2M Na2HP04 (Fischer Scien- interpreted as E, coli 0157:H7, was being recovered on 
tific) and 12' m1 of 0.2M NaH2P04 (Fischer Scientific) MSA supplemented with nalidixic acid, No bacterial growth 
mixed together). The mixture was sterilized and put in an was observed on any of the uninoculated control MSA 
anaerobic jar to facilitate thorough reduction for 1-4 days. 20 plates, 
~ f t e r  reduction, about 10 ml of rumen fluid mixture was Analysis of Variance (ANOVA) on the data for interaction 
reserved as uninoculated with 0.25 ml of E. coli 0157:H7 studies in manure and rumen fluid were performed as a 
cocktail as prepared in the manure experiment. The inocu- 
~ ~ ~ d ~ ~ i ~ ~ d  complete l ~ ~ k  ~~~i~~ (RCBD) using single 
lated mixture was divided into 20 sterile tubes (10 ml each) factor Repeated Measures Analysis of Statistical Analysis 
and keeping one sample for inoculated control, the other 25 System software (SAS Institute Inc., Cary, N.C.). The means 
samples were inoculated with 1 ml of freshly prepared of duplicate plate counts were converted to a log,, CFUlml 
cultures of selected LAB (1 isolate per sample). Each of the scale before analysis. The treatment design was a 20x3 
samples were anaerobically incubated at 37' C. and plated factorial with each plate count as a sampling unit and 
in duplicate on MSA supplemented with nalidixic acid at 0, duplicate plate counts as an experimental unit. Differences 
24 and 48 hours to monitor E. coli 0157:H7 growth. The pH 30 among treatment were determined using LSD (Least 
of all rumen-fluid samples was recorded at 0, 24 and 48 Square Difference) msthod. 
hours. The entire experiment was repeated three times. Based on the results from interaction studies in manure 
The interaction of E, coli 0157:H7 with the selected LAB and rumen fluid, bile tolerance, storage stability and iden- 
was studied in the manure and rumen fluid at 0, 24 and 48 tification profiles, the strains that were finally selected to be 
hours. As expected, none of the strains were different from 35 as CEP were, M35 accession PTA-5249) 
the control in their inhibition against E, coli 0157:H7 at and L411. These two strains were selected for the following 
hours in both rumen fluid and manure. reasons: both showed significant inhibition towards E. coli 0157:H7 in laboratory media (6.1 and 2.0 mm inhibition 
Results from the interaction studies in manure showed 
zones for M35 (ATCC accession no, PTA-5249) and L411 
that at 24 hours, control (no LAB added) showed an increase 40 respectively), manure and fluid (completely elimi- inE. "li counts a ~ ~ r o x i m a t e l ~  2.0 loglo 
nated E, coli at 48 h); both showed increased growth under 
from 5.9 to 7.6 loglo CFU1ml and 3). all bile conditions at all incubation periods; the API system 
strains except H27, T21, 133, 037, P31, P32 and B41 revealed good identification for both isolates; and antibiotic (Pe0.05) reducedE. "li  counts ( a ~ ~ r o x i m a t e l ~  susceptibility tests showed that M35 (ATCC accession no, 
loglo at 24 hours. 45 PTA-5249) was susceptible to all the antibiotics to which it 
ever, at 48 strains 1212, C312, C314, C315, M35 was tested, while L411 was susceptible to 4 of the 6 
accession PTA-5249), A46 and L411 were antibiotics tested. Although strain L411 was resistant to two 
to maintain the reduction in E. coli 0157:H7 counts and the antibiotics (TS and GP), the reason for its selection over difference was significant (Pe0.05) when other strains is that the rest of the strains did not meet more 
pared to the control. These strains were able to reduce E. coli 50 than one selection criteria when to L41 The 0157:H7 numbers from approximately 6.0 log,, CFUlml to selection process is summarized in Table 
4.6 log,, CFUlml over a 48 hour period. No change in pH 
of the treatment samples was observed at 0, 24 or 48 hours, 
as it ranged between 6.1-6.8 at all incubation periods. TABLE 6 
Interaction studies in rumen fluid revealed that at 24 55 Growth of E. coli 0157:H7 (log,, 
hours, strains H27, T21, T28, C314, M35 (ATCC accession CFUIml) in association with cattle 
no. PTA-5249), M38, A43, A46, L411 and R44 significantly isolates in manure at 0, 24 and 48 hours 
(Pe0.05) reduced E. coli counts (between 1 to 4 log,, Sample API o h  2 4 h  4 8 h  
reductions) compared to the control (see Table 7 and FIG. 4). 
Strain M35 (ATCC accession no. PTA-5249) completely 60 El5 P_acidilactici 5.9 7.6 6.6 5.9 6.5 4.9 
eliminated E. coli 0157:H7 at 24 hours by reducing the A46 L. acidophilus 5.9 5.9 5.2 
numbers from 5.6 log,, CFUlml to 1.0 log,, CFUlml. At 48 C314 L. acidophilus 5.9 5.8 4.9 
hours all of the strains except 1212, C312, C315, 037, P32 M35 L. acidophilus 6.1 5.6 4.8 
and B41 significantly inhibited E. coli 0157:H7 compared M38 L. acidophilus 6.0 6.4 5.5 S310 L.acidophilus 5.8 5.9 5.9 
to the control (Pe0.05). Strains H27, C314, M35 (ATCC 65 B41 L , + ~ ~ ~ ~ ~ ~ ~  6.0 6.5 5.7 
accession no. PTA-5249), M38, A43, A46, L411, and R44 R44 L. acidophilus 6.2 6.3 5.8 
eliminated E. coli in rumen fluid at 48 h (reduction from 5.5 
TABLE 6-continued TABLE 8-continued 
Growth of E. coli 0157:H7 (log,, Selection of isolates for 
CFUIml) in association with cattle 
5 competitive exclusion product isolates in manure at 0, 24 and 48 hours 
Sample API Oh 2 4 h  4 8 h  Isolate Interaction Antibiotic 
I212 L. salivarius 5.8 5.9 4.9 Stability Manure Rumen Resistance" Storage 
037 L. cellobiosus 5.9 6.5 5.4 
L411 L. acidophilus 6.2 6.0 5.8 10 B41 - - 3 + 
A43 L. acidophilus 6.1 5.9 5.5 L411 + + 2 + 
H27 L. delb. delb. 6.1 5.9 5.5 R44 - + 2 + 
P3 1 L. acidophilus 6.3 5.7 5.4 
C312 L. acidophilus 6.1 5.4 4.6 
T2 1 Leuconostoc sp. 6.2 6.0 5.6 M35 corresponds to ATCC accession no. PTA-5249 
T28 L. acidophilus 6.0 5.4 5.1 15 "Total number of antibiotics that an isolate was resistant to, out of the six 
I33 L. brevis 6.1 5.6 4.8 antibiotics that the isolates were tested for. 
P32 L. brevis 6.2 5.8 5.0 + indicates a positive result for each particular selection criteria. 
- indicates a negative result for each particular selection criteria. 
IC = Inoculated control 
20 Example 8 
TABLE 7 
Growth of E. coli 0157:H7 (log,, Identification of Strains of Ribotyping and 16s 
CFUIml) in association with cattle Sequence Analysis 
isolates in m e n  fluid at 0. 24 and 48 hours 
25 
Sample API o h  2 4 h  4 8 h  The genotypic fingerprint analysis of 13 isolates, used in 
IC - 5.6 7.1 7.4 manure and rumen fluid interaction studies, was carried out 
C315 P acidilactici 5.6 5.9 6.0 by ribotyping where total DNA of an organism, after isola- 
A46 L. acidophilus 5.5 4.9 1 .O tion, is restricted into multiple fragments (el  kb to >20 kb) 
C314 L. acidophilus 5.6 4.9 1 .O 
M35 L. acidoahilus 5.6 1.0 1 .0 30 using restriction enzyme. The restricted fragments after 
M38 L. acidophilus 5.7 4.9 1 .O separation are subsequently hybridized with a probe targeted 
S310 L. acidophilus 5.7 5.9 2.1 
B41 L. fermentum 5.6 6.1 6.3 to the 16S, 23s or 5 s  ribosomal RNA (rRNA) genes. 
R44 L. acidophilus 5.6 4.9 1 .O Restriction bands containing copies of the rRNA genes are 
1212 L. salivarius 5.6 6.1 6.9 35 then visualized and a characteristic fingerprint is obtained 
037 L. cellobiosus 5.7 5.9 6.1 
L411 L. acidophilus 5.7 4.8 1 .O based on the pattern of the band sizes. To obtain ribotyping 
A43 L. acidophilus 5.3 1.5 1 .0 patterns, isolates were sent to the Laboratory for Molecular 
H27 L. delb. delb. 5.5 3.0 1 .O 
P3 1 L. acidophilus 5.6 5.9 5.8 
C312 L. acidophilus 6.3 5.7 5.6 
T2 1 Leuconostoc sp. 5.6 5.7 5.7 
T28 L. acidophilus 5.6 5.3 5.7 
I33 L. brevis 5.6 6.0 5.9 
P32 L. brevis 5.6 5.9 6.1 
IC = Inoculated control 
TABLE 8 
Typing at Cornell University (Ithaca, N.Y.) as MRS agar 
slant cultures. 
40 The isolates selected after screening for inhibition 
towards E. coli 0157:H7 in manure and rumen fluid were 
also identified by 16s rRNA sequence analysis. In this 
analysis a portion of the 16s rRNA gene of the bacteria was 
45 amplified and sequenced, and then was compared to 
sequences contained in the public database, Genbank, to 
provide matches to the isolate. Samples of selected isolates 
Selection of isolates for were sent as MRS agar slant cultures to the Laboratory for 
competitive exclusion product 
- - 
Molecular Typing at the Cornell University (Ithaca, N.Y.). 
3u 
Isolate Interaction Antibiotic The genotypic identification of the selected cattle isolates 
was done using ribotyping. Isolates H27 and C314 were 
Stability Manure Rumen Resistance" Storage reported to be similar, with C314 having 95% homology 
H27 - + 4 + with H27. Both isolates were identified as L. acidophilus 
1212 + - o + 55 showing 51-60% homology with the Dupont database pat- 
T2 1 - + 4 + 
T28 - + 1 terns. Isolate R44 showed 58-78% homology with L. aci- + 
C312 + - o + dophilus and 58% homology with L. amylovorus when 
C314 + + 5 + compared with the Dupont database. The remaining isolates 
C315 + - 2 + 
I33 - + 1 + did not have a close match with any of the patterns in either 
M35 + + o + 60 the Dupont or LMT database. However, isolates C312 and 
M3 8 - + 2 + T28 were found closely related to each other, sharing many 
037 - - 2 + 
p3 1 - + 2 + similar bands, with T28 showing 91% homology with C312. 
P32 - - 2 + Isolates M35 (ATCC accession no. PTA-5249), T21, L411, 
S310 - + 2 + 
A43 - + 0 65 A46, A43, 133, M38 and 037 also aligned closely together - 
A46 + + 2 - (homology ranging from 94%-97%). Results are shown in 
Tables 9, 10, and 11. 
US 7,323,166 B2 
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TABLE 9 Weimer in Isolation and characterization of acid-and bile- 
tolerant isolates from strains of Lactobacillus acidophilus. J. 
Ribotyping analysis of cattle Dairy Sci. 82: 23-31, 1999, with some modifications. An 
isolates as compared to the DuPont database overnight culture of each strain of selected LAB was pre- 
LAB Strain DuPont Significant YO 5 pared by growing the frozen concentrated culture in MRS 
Code Accession No. Alignments Homology broth for 18-24 hours at 37' C. About 1 ml of the overnight 
H27 DUP5000 L. acidophilus 60% culture was inoculated into 100 ml of MRS broth and 
DUP5001 L. acidophilus 52% incubated further at 37' C. for 18-24 hours. The cells were 
DUP5002 L. acidophilus 51% harvested by centrifugation at 10,000xg for 10 minutes at 
R44 DUP5000 L. acidophilus 58% 
DUP5001 L. acidophilus 78% l o  0-4" C. The pellets were washed once in sterile PBS and 
DUP5002 L. acidophilus 58% resuspended in 100 ml of PBS to obtain a population of 
DUP5005 L. amylovorus 58% lxlo9 CFUlml. Bacterial numbers were determined by 
plating the cell suspension on MRS agar, using appropriate 
15 dilutions, and incubating at 37' C. for 18-24 hours. About 
TABLE 10 1% of the cell suspension was added to a series of tubes 
Ribotyping analysis of cattle conta!ning 10 ml MRS broth (to obtain a population of 
isolates as compared to each other 1x10 CFUlml) acidified with 2M HCl to pH 2, 4, 5, and 7 
(nonacidified/control) and incubated in a water bath at 37' 
LAB Strain Close 
Code Alignment to % Homology 20 C. The growth of the organisms for each pH value was determined at 0, 2, 4 and 24 hours by plating on MRS agar 
H27 C314 95% and incubating at 37' C. The test was repeated three times 
C312 T28 91% for each isolate. 
T2 1 A46 97% 
A43 97% 
037 97% (2) Antibiotic Resistance 25 
I33 96% The isolates chosen for CEP at the end of the screening 
M35 96% procedures were also tested for susceptibility to vancomy- 
L411 95% 
M3 8 94% cin, cephalosporin (cephalothin), and polymixin B belong- 
ing to Category I, 11, and I11 respectively. Agar disc diffusion 
30 test (BBL Sensi-Disc Antimicrobial Susceptibility Test Since M35 accession no' PTA-5249) and L411 Discs, Benton Dickinson Microbiology Systems, Cock- 
were closely aligned together in the ribotyping patterns 
obtained, on]y isolate M35 (ATCC accession no, PTA-5249) e~sville, Md.) was used for testing. An Over- 
was further identified using 16s rRNA sequence analysis. night each grown On MRS agar at 370 C. 
~ ~ ~ l ~ t ~  ~ 3 5  (ATCC accession no, PTA-5249). which was for 18-24 hours, was used to make a direct suspension in 5 
,, 
identified as L. acidophilus by the API fermentation pattern, 35 ml PBS with turbidity equivalent to the 0.5 McFarland 
gave different results with the 16s rRNA analysis. Com- turbidity standard. The cell suspension was streaked on the 
parison of the 16s rRNA sequence of the strain with the entire surface of a Mueller Hinton Agar plate using a sterile 
public database, GenBank, revealed that M35 (ATCC acces- swab dipped into the properly adjusted inoculum. Appro- 
sionno. PTA-5249) had significant homo lo^ to L. crispatus priate discs containing the antibiotic were applied to the agar 
(98%) In view the the 4O and incubated at 370 C, for 16-1 8 hours, After incubation, 
M35 accession PTA-5249) and L411 plates were examined for inhibition zones around the discs. 
with each other in the ribotyping analysis L411 is also 
speculated to be L. crispatus. Recorded zone diameters (mm) were compared to the Zone 
Diameter Interpretive Chart provided with the test kit, to 
TABLE 11 45 examine . the antibiotic susceptibility of the organisms. The 
isolates were considered susceptible to vancomycin, cepha- 
16s rRNA sequence analysis of M35 (ATCC accession losporin, or polymixin B if a zone diameter of greater than 
no. PTA-5249) as compared to GenBank Database. Table 
shows the top five matches to GenBank 15 mm, 18 mm, or 12 mm respectively, was observed around 
the disc. The entire test was replicated three times. 
LAB Strain Genbank Significant 
Code Accession No. Alignments % Homology (No. of 50 Both isolates, M35 (ATCC accession no. PTA-5249) and 
L411, showed increased growth at pH 4.0, 5.0, and 7.0 over 
M35 AF257097 L. crispatus 98% (6341644) a period of 24 hours a; determined by the plate counts. 
AF277096 L. crispatus 98% (6341644) 
Y17362 L. crispatus 98% (6341644) Isolate M35 (ATCC accession no. PTA-5249) showed an 
AF243152 L. crispatus 98% (6341644) increase in growth (0 to 24 h) by approximately 1.0 log,, 
AF243158 L. crispatus 98% (6311643) 55 cycle (7.2 to 8.3 log,, CFUlml) at pH 4.0, and 2.0 log,, 
cycles (6.9 to 9.2 log,, CFUlml) at pH 5.0 and 7.0. Isolate 
L411 showed increased growth by approximately 2.0 log,, 
Example 9 cycles at pH 4.0, 5.0, 7.0. Both isolates failed to survive at 
pH 2.09 as no growth was observed at 2, 4, or 24 hours. 
60 Test for Acid Tolerance and Antibiotic Resistance Results shown in Table 12. 
in LAB Selected for CEP The antibiotic susceptibility test of M35 (ATCC accession 
no. PTA-5249) and L411 towards vancomycin, cepha- 
(1) Acid Tolerance losporin, and polymixin B revealed that both isolates were 
ne isolates that were finally as CEP at the end 65 susceptible to the three antibiotics. Both the isolates exhib- 
of all the screening procedures were further tested for acid ited zones greater than 15 mm, 18 mm, and 12 mm for 
tolerance using the procedure described by Chou, L. and B. vancomycin and cephalosporin respectively. 
21 
TABLE 12 
under anaerobic conditions. The tests in manure and rumen 
fluid were replicated three times. 
Acid tolerance of M35 (ATCC accession no. PTA- The mixtures of developed CEP (M35 (ATCC accession 
5249) and L411 based on their growth (log,, CFUIml) at 
- 
no. PTA-5249)) and strains from a commercial CEP were 
~ H 2 . 0 . 4 . 0 . 5 . 0 a n d 7 . 0 ~ t 0 . 2 . 4 . ~ d 2 4 h  ' further tested for inhibition against E. coli 0157:H7 in 
Time 
Isolate Period pH 2.0 pH 4.0 pH 5.0 pH 7.0 
Example 10 
manure and rumen fluid. None of the CEP mixtures (UNL, 
NPC, and UNL+NPS) showed a reduction in E. coli counts 
in manure over a period of 48 hours when compared to 
l o  control. However, in rumen fluid, UNL+NPC reduced E. 
coli counts considerably at 24 hours (-2 log,, cycles) and 
eliminated E. coli completely at 48 hours (reduction from 
5.5 log,, CFUlml to 1.0 log,, CFUlml), whereas UNL and 
NPC showed a reduction in E. coli counts only at 48 hours 
15 
and not 24 hours. Results shown in Table 13 and FIGS. 5 and 
6. 
TABLE 13 
Preparation of Frozen Concentrated Cultures (FCC) 20 Growth of E. coli 0157:H7 
of Selected LAB (log,, CFUIml) in association with competitive 
exclusion rodupts in manure and rumen fluid 
The strains finally selected as CEP cultures were grown Treatment E. coli counts in Manure E. coli counts in Rumen Fluid 
separately into 200 ml MRS broth at 37' C. for 24 hours. 
Cells were harvested by centrifugation at 10,000xg for 10 25 Oh 2 4 h  4 8 h  Oh 2 4 h  4 8 h  
minutes at 0' C. and pellets resuspended in 20 ml of 10% IC 5.8 7.5 7.1 5.7 7.5 8.1 
non-fat milk solids (NFMS). About 2 ml of each culture UNL 5.7 6.3 6.2 5.7 6.3 4.2 
suspension was transferred to 2 ml vials and immediately NPC 5.7 6.0 6.9 5.7 5.5 4.7 
UNL + NPC 5.7 7.5 7.0 5.9 4.4 1 .O 
transferred to liquid nitrogen. After freezing in liquid nitro- 
30 gen, the vials containing the FCC were stored at -70' C. IC - Inoculated Control; UNL - Mixture of isolates M35 (ATCC accession 
no. PTA-5249) and L411; NPC - Mixture of commercial strains LA51 and 
Example 11 LA45. 
Antagonistic Effect of Developed and Commercial 35 Example 12 
CEP on E. coli 0157:H7 in Manure and Rumen 
Fluid Test for Interaction Among LAB 
M35 (ATCC accession no. PTA-5249) was further tested 
for its antagonism towards E, coli 0157:H7 in manure and 40 The strains as CEP (M35 accession 
fluid with a mixture of commercial strains of no. PTA-5249) and L411) and the commercial strain (LA51) 
u 
CE microorganisms (L. acidophilus LA45, and L. acidophi- used in the interaction studies above were further tested for 
lus LA51) obtained from Nutrition Physiology Corporation inhibition against each other using the agar spot test. An 
(NPC) (Indianapolis, Ind.). Amixture of commercial strains overnight culture of M35 (ATCC accession no. PTA-5249), 
(NPC) was prepared by combining together 1 ml of a 1110 45 L411 or LA5 1 in MRS broth was spot-induced on MRS agar 
dilution (1 ml FCC into 9 ml of sterile 10% NFMS) of each plate and incubated for 24 hours at 370 C, in bags 
strain. The UNL mixture was prepared by flushed with CO, for 30 seconds. About 1 ml of an overnight 
combining together 1 ml of FCC of each selected LAB (M35 
culture of each strain was inoculated individually into 10 ml (ATCC accession no. PTA-5249) and L411). One of the 
selected UNL strains (M35 (ATCC accession no, PTA- 50 qf MRS agar (Difco) to obtain a 'Oncentra- 
5249)) was also combined with one of the commercial tion of approximately 5x10~  CFUlml. This mixture was then 
strains (LA5 1) (1 : 1) and the mixture (UNL+NPC) tested for poured onto the surface of s~ot-inoculated agar plates that 
inhibition towards E. coli 0157:H7 in manure and rumen contained well-grown colonies of test bacteria. After 24 
fluid. hours of incubation at 37' C. inhibitory activity was mea- 
Manure and rumen fluid samples of cattle were obtained 55 sured as the size of inhibition zones around the colony. 
from Animal Science Dept., UNL, and rumen fluid treated Inhibition was considered positive if the width of the clear 
the same way as previously described. Keeping aside 10 g zone around the colonies was 20.5 mm. The test was 
of manure or rumen sample as uninoculated control, about repeated three times, 
40 g of the sample was inoculated with 0.04 ml of four- The LAB used in CE mixtures were also tested for 
strain-cocktail of nalidixic acid-resistant E. coli 0157:H7. 60 
The inoculated sample was divided into of antagonism against each other using the agar spot test. As 
each, Reserving one as inoculated control, each of the results indicated (Table 141, both isolates, M35 (ATCC 
the other was inoculated with 1 of UNL, NPC, accession no. PTA-5249) and L411, were being inhibited by 
orUNL+NPC mixture, All samples were incubated at 37O C. LA51, while isolates M35 (ATCC accession no. PTA-5249) 
and E. coli growth was monitored at 0, 24, and 48 hours by 65 and L411 were inhibiting each other. However, neither of the 
plating on MSA supplemented with nalidixic acid (50 two cattle isolates (M35 (ATCC accession no. PTA-5249) 
pglml). Incubation for tests in rumen fluid was carried out and L411) showed any antagonistic effect against LA5 1. 
US 7,323,166 B2 
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747 (provided by University of Oklahoma) mixed in water 
TABLE 14 and added to the diet at the time of feeding; 
NP 750 standard TTU Burnett Center 90% concentrate 
Inhibition of lactic acid 
bacteria (M35 (ATCC accession no. PTA-5249), L411, and diet with 1 x 1 0 ~  CFU Lactobacillus acidophilus Strain NPC 
LA51) towards each other using agar spot test 5 750 (isolate M35 (ATCC accession no. PTA-5249)) mixed in 
Idibitin Isolates water and added to the diet at the time of feeding. 
Each treatment culture (lactose for the control treatment) 
Zone of Inhibition (mm) 
was prepackaged in aluminum foil packets by personnel of 
Test Isolates LA5 1 L411 M35 Nutrition Physiology Corp., Indianapolis, Ind. The contents 
10 of one packet were sufficient to supply the desired dose of 
M35 1.40 0.99 - 
L411 1.27 - 1.27 microbial culture for the 12 pens of cattle on each treatment. 
LA5 1 - 0.00 0.00 The contents of the packet for each treatment were mixed 
with 2.5 L of distilled water in a plastic sprinkler can, after 
which the contents of the sprinkler can were poured onto the 
15 diet as it mixed in a Rotomix 84-8 mixerldelivery unit. 
Example 13 Experimental Diets. Ingredient composition of the 90% 
Live Animal Studies concentrate diet fed during the experiment is shown in Table 15. These data reflect adjustments for the average dry matter 
- .  
(DM) matter content of feed ingredients for the period 
One hundred (IX5) steers British 20 during which microbial culture treatments were applied, 
breeding (primarily Angus, Hereford, and Angus Here- Each diet contained the same intermediate premix (Table 
were purchased through Industries, Inc. and 15), which supplied protein, various minerals and 
to the Texas Tech University Burnett Center. Rumensin (30 g/ton, DM basis), and Tylan (8 g/ton, DM 
Following arrival, the cattle were unloaded and processed. basis), 
Processing included: 1) individual body weight (BW) mea- 25 
surement; 2) uniquely numbered ear tag in the left ear; 3) 
vaccination with Ultrachoice 7 (Pfizer Animal Health; Lot TABLE 15 
NO. S900024 Exp. J u ~ .  5,2001 and Lot NO. S903222B Exp. Ingredient composition (%, DM basis) 
Sep. 10, 2001); 4) vaccination with Bovishield 4+Lepto of the 90% concentrate experimental diet 
(Pfizer Animal Health; Ser. No. SNA019266lA013371 Exp 30 
Ingredient Percentage of DM Oct. 1, 2002; Ser. No. SNA018354lA019248 Exp. Sep. 11, 
2002); and 5) treatment down the back line with Dectomax Alfalfa hay, ground 4.96 
(Pfizer Animal Health; Lot No. K9T04911 Exp. July, 2002). Cottonseed hulls 5.04 
Steam-flaked corn 64.60 Steers were sorted to 37 concrete, partially slotted floor pens Dry-rolled corn 10.15 
with five steers per pen and offered 10 lblsteer of a 65% 35 Cottonseed meal 4.82 
concentrate starter diet. On Jun. 6, 2001 all cattle switched Molasses 4.12 
to a 70% concentrate diet, and the switch to an 80% Fat (yellow grease) 2.93 
Urea 0.90 
concentrate diet occurred on Jun. 11, 2001. Premix" 2.48 
All cattle were weighed on Jun. 12, 2001 to initiate the 
- 
preliminary phase of the experiment, At this time, each steer 40 "Composition of the premix was as follows: cottonseed meal = 23.9733; 
was implanted with Revalor Lot No, 321 Exp, high-calcium limestone = 42.1053; dicalcium phosphate = 1.0363; potas- 
sium chloride = 8.000; magnesium oxide = 3.5587; ammonium sulfate = 
2002) in the right ear. Pen assignments were 6.6667: salt = 12.000: cobalt carbonate = 0.0017: coooer sulfate = 0.1572: 
, L L  
retained from the original sdrt that had occurred at the time iron sulfate = 0.1333;EDDI = 0.0025; manganese oxide = -0.2667; sele-' 
of arrival processing, on J ~ ,  16, 2001 all cattle were nium premix, .2% Se = 0.1000; zinc sulfate = 0.8251; vitamin A, 650,000 
switched to the final 90% concentrate diet ( ~ ~ b l ~  1). ~~~h 45 IU/g = 0.0122; vitamin E, 275 IU/g = 0.1260; Rumensin, 80 mg/lb = 
0.6750; and Tylan, 40 mg/lb = 0.3600. Concentrations by the certain 
steer was weighed on Jul. 31, 2001 (49 d on feed), and an ingredients are on a 90% DM basis, 
individual fecal sample was obtained to test for shedding of 
E. coli 0157:H7. Procedures and Data Collection. Standard procedures at 
Treatment and Pen Assignments. Five steers (one with the Burnett Center were used throughout the 
injured foot, one with an injured shoulder, one that did not 50 The three treatment diets were mixed in a 45-cubic foot 
gain BW for the first 49 d, and the two steers of lightest BW paddle mixer. The Burnett Center feed 
among the remaining cattle) were designated as extra cattle, system is a batch- 
leaving 180 steers for the experiment. ing system. A printout of the weight of each dietary ingre- 
Each steer was weighed on Aug. 14, 2001 to begin the dient was recorded on a daily ingredient usage output from 
55 the computerized batching system. Once the total amount of 
study. Treatments (control and the two Lactobacillus acido- feed for a given treatment was mixed, the mixed batch was philus cultures) were applied when the cattle were fed after 
released from the Marion paddle mixer and delivered by a they were returned to their pens. drag-chain conveyer to a Rotomix 84-8 delivery system. 
The was a randomized After feed was delivered, and the mixer unit for the Rotomix 
with pen as the unit (I2 pens per each 60 84-8 unit was operating, the contents of the can for 
the three treatments with five steers per pen for a a given treatment were poured onto the diet, After for 
180 steers). The three treatments were as follows: approximately 4 to 5 min, the quantity of feed allotted to 
Control standard TTU Burnett Center 90% concentrate each of the 12 pens within treatment was then weighed to the 
diet with carrier (lactose) only mixed in water and added to nearest 1 lb by use of the load cells and indicator on the 
the diet at the time of feeding; 65 Rotomix 84-8 unit. Feeding order of treatment diets 
NP 747 standard TTU Burnett Center 90% concentrate throughout the experiment was Control, NPC 747, and NPC 
diet with 1 x 1 0 ~  CFU Lactobacillus acidophilus Strain NPC 750. Clean-out of the Rotomix 84-8 was monitored closely 
US 7,323,166 B2 
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to avoid cross-contamination of diets, and at least one batch Animal Research Center in Clay Center, NE. Briefly, ninety 
of a diet from another experiment (equivalent to the Control milliliters of GN-VCC broth were inoculated with 10 g of 
diet) was mixed between the NPC 747 and NPC 750 feces (GN-VCC is GN broth with 8 mglmL of vancomycin, 
treatment diets. 50 ng/mL of cefixime and 10 mglmL of cefsulodin) and 
Dry matter determinations on ingredients used in the 5 incubated for 6 at 370 C, E, coli cells were subjected to 
experimental diets were made every 2 wk throughout the immunomagnetic separation by mixing 1 mL of the culture 
experiment. These ingredient DM values were used to 
calculate the DM percentage of each dietary ingredient above with 20 of D ~ n a l  beads for 30 min at room 
during the experiment, addition, samples of mixed feed temperature. Beads were washed three times in PBS-Tween 
delivered to feed bunks were taken weekly throughout the l o  20 and 50 mL of the bead-bacteria mixture were spread on 
experiment. These bunk sample DM values were used to to CT-SMAC plates containing 50 ng/mL of 
compute average DM intake (DMI) by the cattle in each pen. cefixime and 2.5 uglmL of tellurite) and streaked for isola- 
Samples of feed taken from the bunk were composited for tion. Plates were incubated overnight at 37O C. Three sor- 
the entire preliminary period and for each interval in which bitol-negative colonies were picked and streaked for isola- 
cattle were weighed (typically 28-d intervals) after the 15 tion on CT-SMAC (to verify purity of colony selection). 
microbial culture treatments were initiated. Composited feed Plates were incubated overnight at 370 C, A single colony 
samples were ground to pass a 2-mm screen in a Wiley mill from the CT-SMAC plate above was selected and inoculated 
and analyzed for DM, ash, crude protein (CP), acid detergent 
fiber (ADF), Ca, and P (AOAC, 1990). into MacConkey agar, Fluorocult agar, and MacConkey 
Each feed bunk of the 36 pens was evaluated daily. The 20 broth. Broth was incubated overnight at 370 C. MUG- 
of feed remaining in each bunk was estimated, and negative, lactose-positive colonies were selected, and 
the suggested daily allotment of feed for each pen was indole, TSI, and VP tests were conducted on selected ~010- 
recorded. This bunk-reading process was designed to allow nies. Colonies that were indole-positive, MA, or KIA plus 
for little or no accumulation of unconsumed feed (0 to 1 lb gas and VP-negative were boiled (using cells from the 
Per pen). A computer printout of the intake by each Pen for 25 MacConkey broth above) and tested for the 0 1  57 antigen 
the previous 3-d period was available each morning to assist using a ~~~~l latex agglutination kit, colonies were sub- 
with bunk reading. Pens of cattle that maintained a given cultured on to blood agar, The H7 agglutination andAPI 20 
level of feed intake for a 3-d period were challenged to tests were conducted on 0157-positive cells for confirma- 
consume a higher level (0.4 lblsteer challenge). Each chal- 
lenge level was maintained for a 3-d period when the pen 30 
accepted the challenge and consumed all the feed offered. Results. Upon arrival at the feedlot, only three of the 
The ultimate goal of the challenge process was to ensure that animals had detectable amounts of the pathogen. Just before 
the cattle were consuming the maximum quantity of feed probiotic supplementation, 24 of the animals had detectable 
possible. Feed bunks were cleaned, and u n ~ ~ n s u m e d  feed amounts of the pathogen in fecal grab samples. These 
was weighed (Ohaus electronic scale, 20.1 lb) at intervals 35 were distributed equally among the three treatment 
corresponding to intermediate weigh dates throughout the 
trial. Dry matter content of these bunk weigh back samples 
was determined in a forced-air oven by drying AS FIGS. 7 and 8 show, both individual animal samples 
(typically 20 h) at 100' C. All weights for DM determina- and Pen samples taken 14 and 28 days following the start of 
tions were obtained on an Ohaus electronic balance (20.1 g). 40 the treatment indicate that NPC 750 and NPC 747 signifi- 
The DM1 by each pen was calculated by multiplying the DM cantly reduced shedding compared to the control treatment. 
content of the delivered feed by the total feed delivery to Early in treatment (day 14) NpC 750 was more effective at 
each Pen, with ~~i-rection for the DM of any feed weighed reducing shedding than NPC 747. On day 42, there were 
back from each pen. significant differences for individual animal samples but not 
Statistical Analyses. All performance data were analyzed 45 for pen data, Again, when looking at individual samples, 
with pen as the experimental unit. A complete randomized 
shedding was reduced in NPC treatment groups compared to block design was employed, and computations were made 
with the GLM procedure of SAS (1987). Pen means for the COntrO1 group. 
daily gain (ADG) and average daily DM1 were included in Analyzed nutrient content of the 90% concentrate diet fed 
the data file, and feed:gain ratio was computed as the 50 during the treatment period was generally in close agree- 
quotient of daily DM1 divided by ADG. The effect of ment with formulated values. Averaged over the treatment 
treatment and block were included in the model for pen- feeding period, the diet contained (DM basis) 12.69% CP, 
based data. 4.5% ash, 8.82% ADF, 0.56% Ca, and 0.30% P. 
Microbiological Measurements Monitored. Fecal samples Average daily gain (Table 6) did not differ among 
were taken directly from the rectum of the animal initially 55 treatments (P>O,lO), but cattle in both the Lactobacillus 
and every 28 d thereafter until they received probiotic 
culture groups had numerically higher ADG for the first 28 
supplementation. Following probiotic supplementation, 
fecal samples were taken every 14 d. A newly developed d of the treatment feeding period. In addition, cattle in the 
assay for the detection of E. coli 0157:H7 was used to detect NPC 747 andNPC 750 treatments tended (P50.144) to have 
the organism in this study (modification of Elder, R, O,, J, 60 greater adjusted ADG adjusted BW) 
E. Keen, G. R. Siragusa, G. A. Barkocy-~allagher, M, for the overall study than control cattle. ~ r y  matter intake 
Koohmarie, and W. W. Lagreid. 2000. Correlation of entero- did not differ among treatments (P>0.10) for the first 28 d or 
hemorrhagic ~ ~ ~ h ~ ~ i ~ h i ~  coli 0 1  5 7 : ~ 7  prevalence in feces, for the overall treatment period. Similarly, feed:gain ratio 
hides, and carcasses of beef cattle during processing. Proc. did not differ (P>0.10) for the first 28 d or for the ~veral l  
Natl. Acad. Sci. 97: 2999-3003). This method is very sen- 65 period; however, feed:gain ratio based on adjusted ADG 
sitive and will detect E. coli 0157:H7 when numbers are tended (P50.067) to be improved for the two probiotic 
very low. The method was originally developed at the Meat culture treatments than for the control. 
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TABLE 16 What is claimed is: 
1. A composition comprising a biologically pure, isolated 
Effects of live cultures of 
Lactobacillus acidophilus Strains NPC 747 Lactobacillus acidophilus strain ATCC accession Number 
and NPC 750 on performance by finishing beef steers PTA-5249, 
Treatment wherein said strain inhibits Escherichia coli 0157:H7; 
wherein said strain is resistant to from 1 to 4 antibiotics 
Item Control (C) NPC 747 NPC 750 SE" 
selected from the group consisting of erythromycin, 
Initial BW, ~b 1,037.2 1,029.1 1,029.6 2.38 tetracycline, ampicillin, grepafloxicin, levofloxacin, tri- 
Final BW, Ib 1,277.1 1,271.5 1,283.4 6.90 10 
Adjusted final BW, Ib' 1,272.1 1,276.4 1,283.4 7.69 methoprim-sulfamethoxazole, vancomycin, cephal- 
Daily gain, Ib othin and polymyxin B, and 
d o to 28 4.07 4.28 4.33 0.150 wherein the inhibition occurs in the ruminal fluid and 
d 0 to end 3.50 3.49 3.65 0.101 manure of cattle. 
Adjusted 0 to end' 3.44 3.58 3.69 0.106 15 
  ail^ DMI, bllsteer 
d 0 to 28 
d 0 to end 
20.02 20.29 20.36 0.264 2. The composition of claim 1, wherein said Escherichia 
20.54 20.32 20.85 0,249 coli 0157:H7 is nalidixic acid-resistant. 
Feed: gain 
d o to 28 4.94 4.84 4.73 0.133 20 3. The composition of claim 1, wherein said strain is 
d 0 to end 5.94 5.92 5.76 0.116 tolerant to bile. 
Adjusted d 0 to end 6.01 5.75 5.66 0.127 
4. The composition of claim 3, wherein the bile is oxgall. 
control = standard T.U. Burnett Center 90% concentrate diet with carrier 
(lactose) only mixed in water and added to the diet at the time of feeding; 
NOC 747 = Control + 19g CAU Lactobacillus acidophilus Strain NPC 25 5. The composition of claim 1, wherein said strain will 
747 per animal; NPC 750 = Control + 1 x log CAU Lactobacillus acido- remain viable when exposed to an environment maintained 
hilus Strain NPC per animal. Average days on feed = 70. 
q o o l e d  standard error of treatment means, n = 12 pens per treatment at 0" C. 
'Adjusted final BW was calculated as follows: (Hot carcass weightlaver- 6. The composition of claim 5, wherein said exposure is 
age dress of 62.41%). Adjusted daily gain was calculated as follows: (Ad- for three months, justed final BW - initial BW)/days on feed. Adjusted feed:gain was the 30 
ratio of daily DM1 and adjusted daily gain. 
* * * * *  
